Finance

Beta
Lists
2157:HKG
Lepu Biopharma Co Ltd
HK$3.78
+4.71%
(+0.17) 1D
Jun 10, 4:09:06 PM GMT+8  ·   HKD
All symbols
SymbolPriceChange% Change
Generating top insights for 2157...
Open
HK$3.66
High
HK$3.82
Low
HK$3.56
Mkt. cap
6.82B
Avg. vol.
8.69M
Volume
12.73M
P/E ratio
21.77
52-wk high
HK$10.50
52-wk low
HK$3.55
EPS
HK$0.17
Shares outstanding
1.80B
No. of employees
710
Open
HK$3.66
High
HK$3.82
Low
HK$3.56
Mkt. cap
6.82B
Avg. vol.
8.69M
Volume
12.73M
P/E ratio
21.77
52-wk high
HK$10.50
52-wk low
HK$3.55
EPS
HK$0.17
Shares outstanding
1.80B
No. of employees
710
Analyst outlook
Analyst Ratings
Based on 1 analyst giving stock ratings to 2157 in the past 3 months
Buy
Buy
1
Hold
0
Sell
0
12 month forecast
Based on 1 Wall Street analyst offering 12 month price targets for 2157 in the last 3 months.
Highest
Current HK$3.78
HK$8.10 (+114.29%)
Average
HK$8.10 (+114.29%)
Lowest
HK$8.10 (+114.29%)
News stories
From sources across the web
About Lepu Biopharma Co Ltd
CEO-
Employees710
Founded2018
Headquarters-
SectorBiotechnology
Previous reportsAll values in CNY
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in CNY
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Revenue
232.97M
232.97M
234.46M
234.46M
Cost of goods sold
13.70M
13.70M
31.09M
31.09M
Cost of revenue
13.70M
13.70M
31.09M
31.09M
Research and development expenses
101.12M
101.12M
99.23M
99.23M
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
76.63M
76.63M
100.60M
100.60M
Operating expense
188.88M
188.88M
220.80M
220.80M
Total operating expenses
202.58M
202.58M
251.89M
251.89M
Operating income
30.39M
30.39M
-17.43M
-17.43M
Other non operating income
-8.81M
-8.81M
-7.39M
-7.39M
EBT including unusual items
14.65M
14.65M
115.67M
115.67M
EBT excluding unusual items
15.10M
15.10M
-29.96M
-29.96M
Income tax expense
-
-
875.00K
875.00K
Effective tax rate
-
-
0.76%
0.76%
Other operating expenses
11.13M
11.13M
20.96M
20.96M
Net income
20.87M
20.87M
109.81M
109.81M
Net profit margin
8.96%
8.96%
46.83%
46.83%
Earnings per share
-
-
-
-
Interest and investment income
1.50M
1.50M
1.20M
1.20M
Interest expense
-7.13M
-7.13M
-6.95M
-6.95M
Net interest expenses
-5.64M
-5.64M
-5.75M
-5.75M
Depreciation and amortization charges
-
-
-
-
EBITDA
52.78M
52.78M
-96.50K
-96.50K
Gain or loss from assets sale
-
-
-456.50K
-456.50K
AI content may include mistakes. Learn more

Research

AI content may include mistakes. Learn more